Abstract:The risk factors for type 2 diabetes, and the association between diabetes and cancer are two hot topics in translational endocrinology that have caused researchers’ high attention. Bisphenol A (BPA) is one of the world’s highest production volume chemical in use. People widespreadly and continuously expose to BPA, and whether BPA associates with human health needs further research. The association between diabetes and cancer has been realized as a very important issue in the field of diabetes and diabetes care. However, how diabetes is linked with cancer and whether the duration of diabetes, as well as the degree of glycemic controls modify the risk of cancer are not well defined. We recruited 3423 participants aged 40 years or older from Songnan Community, Baoshan District, Shanghai, and all the participants were underwent a 75-gram oral glucose tolerance test and blood and urine samples were collected. Risk evaluation of cancers in Chinese diabetic Individuals: a longitudinal (REACTION) study is an effort to evaluate thoroughly the risk of site specific cancers in Chinese diabetic individuals. In 2011, a study population of 250,000 people was identified from 25 communities across China, aims to research the interaction between type 2 diabetes and cancer, as phase I of a prospective study. Our study showed that the detection rate of urinary BPA was 87.7%, with a median value of 0.81 ng/mL. Higher levels of urinary BPA associated with a higher prevalence of type 2 diabetes (OR:1.37, 95%CI: 1.08-1.74), generalized obesity(OR: 1.50, 95%CI: 1.15-1.97), abdominal obesity(OR:1.28, 95%CI: 1.03-1.60), insulin resistance(OR: 1.37, 95%CI: 1.06-1.77), and low-grade albuminuria (OR: 1.23, 95%CI: 1.13-1.34). Urinary BPA was positively associated with free triiodothyronine (FT3) (men: β = 0.011, P = 0.003; women: β = 0.013, P < 0.001) and negatively associated with thyroid-stimulating hormone (TSH) (men: β = -0.065, P = 0.002; women: β = -0.11, P < 0.001), and higher urinary BPA was associated with high thyroid function (OR: 1.68, 95% CI: 1.24-2.27). Results from the REACTION study indicated that type 2 diabetes associated with higher prevalence of all types of cancer and digestive system malignant tumors. BPA might be a risk factor for endocrine diseases, and people should eliminate BPA exposure in daily life. The REACTION study will provide clinical evidence for the interaction between diabetes and cancers.

Diabetic Nephropathy is Associated with Prostate-Specific Antigen Levels in Type 2 Diabetes Mellitus

Association of Type 2 Diabetes Mellitus with Pathological Grade of Prostate Cancer and Prostate-Specific Antigen

Association between serum prostate-specific antigen concentrations and the risk of developing type 2 diabetes mellitus in Chinese men: A cohort study

Clinical Characteristics of Diabetic Nephropathy in Patients with Type 2 Diabetic Mellitus Manifesting Heavy Proteinuria: a Retrospective Analysis of 220 Cases.

Association of Diabetes Mellitus with Prostate Cancer Grade and Prostate-Specific Antigen in Chinese Biopsy Population

The Association of Diabetes with Risk of Prostate Cancer Defined by Clinical and Molecular Features

Diabetes mellitus reduces prostate cancer risk - no function of age at diagnosis or duration of disease.

Serum Uric Acid is Independently Associated with Diabetic Nephropathy but Not Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus

Why does diabetes offer protective effects against prostate cancer? The possible role of its microvascular complications

The association between diabetes mellitus and prostate cancer: a meta-analysis and Mendelian randomization

Clinical Studie of Diabetic Nephropathy with Urinary Protein Negative in Patients with Type 2 Diabetes Mellitus

Diabetes Mellitus and Prostate Cancer Risk of Different Grade or Stage: A Systematic Review and Meta-Analysis

Translational research in type 2 diabetes

Low Serum Dehydroepiandrosterone Is Associated With Diabetic Kidney Disease in Men With Type 2 Diabetes Mellitus

Relationship between diabetes mellitus and benign prostatic hyperplasia

Correlation of Diabetes Control with Benign Prostatic Hyperplasia in T2DM Patients

Plasma Nt-Probnp is Independently Associated with Albuminuria in Type 2 Diabetes

Effects of Diabetes Mellitus and Metformin Administration on Prostate Cancer Detection at Biopsy among Chinese Men: a Case-Control Study.

Renal Pathological Implications in Type 2 Diabetes Mellitus Patients with Renal Involvement

Analysis of platelet and monocyte-to-lymphocyte ratio and diabetes mellitus with benign prostatic enlargement

Increased Risk of Cancer in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study in China